Wednesday, November 11, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

Urozen Capsules Introduces Urozen Multi-Ingredient Dietary Supplement For Prostate Support

October 15, 2026
in GlobeNewswire, Web3
Reading Time: 21 mins read
5
SHARES
249
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

U oze Capsules is a me ‘s well ess dieta y suppleme t featu i g zi c, bota ical ext acts, L-A gi i e HCl, pumpki seed, ettle, a d additio al pla t i g edie ts.

Ogde , UT, Oct. 14, 2026 (GLOBE NEWSWIRE) — U oze Capsules i t oduces a multi-i g edie t dieta y suppleme t fo mulated with zi c, ami o acids, a d a combi atio of bota ical i g edie ts. The U oze fo mulatio i cludes lo gjack, maca, L-A gi i e HCl, Asia gi se g, eleuthe o gi se g, pumpki seed, ettle, a d a b oad bota ical ble d. The p oduct is positio ed withi the me ‘s well ess a d p ostate-suppo t suppleme t catego y.

Official Website U oze

The i t oductio of U oze p ovides a oppo tu ity to exami e the i g edie ts i cluded i the fo mulatio , thei established ut itio al oles, thei histo y of use, a d the impo ta ce of u de sta di g scie tific evide ce whe evaluati g dieta y suppleme ts. The fo mulatio combi es seve al i g edie t catego ies i a capsule-based p oduct, b i gi g togethe ut itio al mi e als a d pla t-de ived compo e ts.

U oze is pa t of a b oade catego y of dieta y suppleme ts that combi e multiple i g edie ts i a si gle fo mulatio . Evaluati g such p oducts equi es atte tio to i g edie t ide tity, se vi g qua tities, ma ufactu i g quality, labeli g t a spa e cy, a d the evide ce available fo the fi ished p oduct.

U de sta di g U oze Fo mulatio

U oze i g edie t p ofile i cludes seve al compo e ts with diffe e t ut itio al a d bota ical backg ou ds. Zi c is a esse tial mi e al, while L-A gi i e HCl is a fo m of the ami o acid L-A gi i e. Lo gjack, maca, Asia gi se g, eleuthe o gi se g, pumpki seed, a d ettle ep ese t the bota ical po tio of the fo mulatio .

The b oad bota ical ble d is a othe listed compo e t of U oze . Its full compositio a d the qua tities of its i dividual i g edie ts should be co fi med th ough the p oduct’s complete label a d suppo ti g docume tatio .

Combi i g multiple i g edie ts does ot automatically establish a pa ticula health outcome. The sig ifica ce of a fo mulatio depe ds o the amou t of each i g edie t, the p epa atio used, the quality of the aw mate ials, a d the evide ce suppo ti g the i te ded use.

Fo U oze , the disti ctio betwee i g edie t i fo matio a d demo st ated p oduct effective ess is impo ta t. Resea ch i volvi g a i dividual i g edie t ca ot automatically be applied to the complete fo mulatio .

Zi c a d Its Nut itio al Role

Zi c is a esse tial mi e al i volved i o mal immu e fu ctio , DNA sy thesis, p otei sy thesis, cell divisio , a d wou d heali g. The body equi es zi c i elatively small amou ts, maki g adequate dieta y i take a impo ta t pa t of ge e al ut itio .

Foods co tai i g zi c i clude meat, seafood, dai y p oducts, legumes, uts, seeds, a d ce tai fo tified foods. Dieta y suppleme ts ca p ovide a additio al sou ce whe ut itio al i take is i sufficie t.

Zi c appea s i ma y me ‘s well ess fo mulatio s because of its established ole i o mal physiological p ocesses. Howeve , its i clusio i U oze does ot i depe de tly demo st ate that the p oduct p eve ts p ostate co ditio s o imp oves u i a y symptoms.

The qua tity of zi c is a impo ta t co side atio whe evaluati g U oze . Excessive i take ca cause ausea a d othe gast oi testi al effects, while p olo ged high i take may i te fe e with coppe abso ptio . Co sume s should co side zi c f om all dieta y suppleme ts athe tha evaluati g each p oduct sepa ately.

The Suppleme t Facts pa el should be co sulted to establish the amou t of zi c p ovided pe se vi g a d to dete mi e whethe additio al ut itio al i fo matio is available.

Lo gjack a d Maca

Lo gjack, scie tifically k ow as Eu ycoma lo gifolia, is a pla t t aditio ally used i pa ts of Southeast Asia. Its oots have bee i co po ated i to he bal p epa atio s a d i vestigated i esea ch elati g to aspects of me ‘s health.

Maca, o Lepidium meye ii, is a pla t ative to the A dea egio of South Ame ica. Its oot has a histo y of food use a d is also i cluded i dieta y suppleme t fo mulatio s.

Both i g edie ts have att acted scie tific i te est, but the evide ce va ies acco di g to the p epa atio , study desig , dosage, a d outcome measu ed. Fi di gs f om p elimi a y i vestigatio s should ot be t eated as co clusive evide ce of a health be efit.

I U oze , lo gjack a d maca co t ibute to the bota ical compositio . The exact qua tities, pla t pa ts, a d ext act specificatio s a e eleva t to u de sta di g the fo mulatio . Without these details, it is ot possible to dete mi e whethe the i g edie ts co espo d to p epa atio s exami ed i pa ticula studies.

The p ese ce of these bota icals should the efo e be u de stood as a desc iptio of the p oduct’s compositio athe tha p oof of a specific p ostate- elated effect.

L-A gi i e HCl a d Ami o Acid Suppleme tatio

L-A gi i e is a ami o acid i volved i seve al physiological p ocesses, i cludi g the p oductio of it ic oxide. Nit ic oxide pa ticipates i egulati g blood vessel fu ctio . L-A gi i e HCl is a fo m used i dieta y suppleme t fo mulatio s.

Resea ch has exami ed L-A gi i e i diffe e t health co texts, although esults va y ac oss populatio s a d study co ditio s. Evide ce i volvi g the i g edie t does ot establish that eve y suppleme t co tai i g it p oduces the same outcome.

Fo U oze , the amou t of L-A gi i e HCl pe se vi g is eleva t to a complete assessme t of the fo mulatio . The i g edie t’s i clusio does ot establish a specific effect o p ostate health, u i a y fu ctio , o othe cli ical outcomes.

L-A gi i e may also i te act with ce tai medicatio s, i cludi g it ates a d some medici es that lowe blood p essu e. I dividuals taki g medicatio o ma agi g a existi g health co ditio should co sult a qualified healthca e p ofessio al befo e usi g p oducts co tai i g this i g edie t.

Asia Gi se g a d Eleuthe o Gi se g

U oze i cludes Asia gi se g a d eleuthe o gi se g amo g its listed bota ical i g edie ts. Despite thei simila commo ames, these pla ts a e bota ically disti ct.

Asia gi se g, ge e ally ide tified as Pa ax gi se g, has a lo g histo y of use i t aditio al East Asia medici e. Its oots co tai compou ds k ow as gi se osides, which have bee i vestigated i labo ato y a d cli ical esea ch.

Eleuthe o, ide tified as Eleuthe ococcus se ticosus, is a sepa ate pla t used i t aditio al p epa atio s a d mode bota ical suppleme ts. It is sometimes called Sibe ia gi se g, although it does ot belo g to the Pa ax ge us.

Resea ch o these pla ts exami es diffe e t outcomes, a d the available evide ce va ies by p epa atio a d i te ded use. Results associated with Asia gi se g should ot automatically be att ibuted to eleuthe o, o vice ve sa.

U oze i g edie t list ide tifies both bota icals, but thei qua tities, pla t pa ts, a d ext act specificatio s should be ve ified th ough complete p oduct labeli g. These details help co sume s u de sta d the i g edie ts mo e p ecisely.

Pumpki Seed a d Nettle

Pumpki seed a d ettle a e additio al compo e ts of U oze fo mulatio . Both have histo ies of use i foods o t aditio al bota ical p epa atio s a d a e i cluded i va ious dieta y suppleme t p oducts.

Pumpki seeds p ovide ut ie ts such as fats, p otei , a d mi e als. Ce tai pumpki seed p epa atio s have also bee i vestigated i esea ch co ce i g u i a y a d othe health outcomes. Howeve , the fi di gs depe d o the p epa atio used, the study populatio , a d the outcome exami ed.

Nettle commo ly efe s to U tica dioica, a pla t used i t aditio al he bal p actices. Diffe e t pa ts of the pla t may be used i food p oducts a d bota ical p epa atio s, a d thei compositio ca va y.

Resea ch i volvi g ettle has exami ed seve al a eas of health, but evide ce fo o e p epa atio o co ditio ca ot be ge e alized to all ettle-co tai i g p oducts. T aditio al use alo e does ot establish that a pa ticula fo mulatio imp oves p ostate health.

Fo U oze , i fo matio about the pla t pa ts, ext act types, a d i g edie t qua tities would help cla ify the p ecise compositio . Whole-pla t powde s a d co ce t ated ext acts ca diffe i thei chemical cha acte istics, maki g accu ate labeli g impo ta t.

The B oad Bota ical Ble d

The b oad bota ical ble d listed i U oze ep ese ts a othe pa t of the p oduct’s multi-i g edie t compositio . Bota ical ble ds may combi e multiple pla t-de ived i g edie ts withi a si gle suppleme t.

The te m itself does ot ide tify eve y compo e t o establish the qua tity of each i g edie t. A complete i g edie t decla atio is ecessa y to u de sta d the ble d’s compositio a d assess its eleva ce to the ove all fo mulatio .

Co sume s evaluati g U oze should co sult the full p oduct label fo additio al bota ical ames, i g edie t qua tities whe e disclosed, a d a y available ext act o sta da dizatio i fo matio .

Ma ufactu i g quality is also eleva t to bota ical suppleme ts. Pla t ide tity, g owi g co ditio s, ha vesti g, p ocessi g, sto age, a d testi g ca i flue ce i g edie t co siste cy. App op iate quality-co t ol p ocedu es ca help ve ify i g edie t ide tity a d sc ee fo eleva t co tami a ts.

Quality co t ols a d cli ical effective ess a e sepa ate co side atio s. Evide ce that a p oduct meets ce tai ma ufactu i g sta da ds does ot automatically demo st ate that it p oduces a specific health outcome.

P ostate Suppo t a d Scie tific Evide ce

The te m p ostate suppo t is used b oadly i the me ‘s well ess catego y. It ca efe to ge e al i te est i p ostate health o u i a y fu ctio , but these a eas e compass diffe e t physiological p ocesses a d medical co ditio s.

P ostate e la geme t, p ostatitis, a d p ostate ca ce have disti ct cha acte istics a d equi e diffe e t app oaches to diag osis a d ca e. Symptoms such as f eque t u i atio , ighttime u i atio , u ge cy, weak u i e flow, o difficulty emptyi g the bladde may have seve al possible causes.

Although some i g edie ts fou d i U oze have bee i vestigated i elatio to me ‘s health o u i a y outcomes, the evide ce fo i dividual i g edie ts does ot establish the effective ess of the complete p oduct. The fi ished fo mulatio would eed app op iate evide ce add essi g its specific compositio a d i te ded use.

It is impo ta t to disti guish t aditio al i g edie t use f om p elimi a y esea ch a d well-desig ed cli ical studies. These sou ces of i fo matio p ovide diffe e t levels of evide ce a d should ot be p ese ted as i te cha geable.

U oze ‘s i te ded p oduct catego y should ot be i te p eted as p oof that it p eve ts, diag oses, t eats, o cu es a medical co ditio . Dieta y suppleme ts should ot eplace p ofessio al evaluatio o p esc ibed t eatme t.

Pe siste t u i a y symptoms, blood i the u i e, pai ful u i atio , o othe co ce i g cha ges wa a t medical assessme t. I ability to u i ate equi es u ge t medical atte tio .

Label T a spa e cy a d P oduct Quality

Clea labeli g helps co sume s u de sta d what a dieta y suppleme t co tai s a d how it should be used. Fo U oze , eleva t i fo matio i cludes se vi g size, zi c qua tity, L-A gi i e HCl qua tity, i dividual bota ical i g edie ts, a d the compositio of the b oad bota ical ble d.

Othe useful details may i clude bota ical ames, pla t pa ts, ext act atios, sta da dizatio i fo matio , alle ge decla atio s whe e applicable, di ectio s fo use, sto age i st uctio s, a d ma ufactu e o dist ibuto co tact i fo matio .

Quality docume tatio may p ovide fu the i fo matio about i g edie t ide tity, pu ity, ma ufactu i g p actices, a d testi g fo eleva t co tami a ts. A y thi d-pa ty testi g o ce tificatio claim should be suppo ted by ve ifiable docume tatio .

Co sume s should also co side the possibility of ove lappi g i g edie ts whe usi g multiple suppleme ts. Total ut ie t i take a d pote tial i te actio s ca be impo ta t, pa ticula ly fo people taki g medicatio o ma agi g o goi g health co ditio s.

The label emai s a impo ta t sou ce of i fo matio , but it ca ot eplace pe so alized medical advice. People with questio s about p ostate health should co sult a app op iate healthca e p ofessio al.

Respo sible Use of Multi-I g edie t Suppleme ts

Multi-i g edie t fo mulatio s combi e substa ces that may diffe i thei safety p ofiles, esea ch histo ies, a d app op iate uses. Evaluati g U oze the efo e i volves mo e tha ide tifyi g its listed i g edie ts.

The qua tities of i dividual compo e ts, the quality of thei p epa atio s, a d the complete p oduct’s safety i fo matio a e all eleva t. Without ve ified qua tities a d detailed fo mulatio i fo matio , co sume s ca ot eliably compa e the p oduct with specific p epa atio s used i scie tific esea ch.

Co sume s should be cautious of claims p omisi g gua a teed outcomes o suggesti g that a suppleme t wo ks the same way fo eve yo e. I dividual espo ses ca va y, a d o si gle suppleme t is app op iate fo eve y pe so .

People co side i g U oze should eview its complete label, follow the stated di ectio s, a d seek p ofessio al advice whe ecessa y. This is pa ticula ly impo ta t fo i dividuals who take p esc iptio medicatio , have existi g health co ditio s, o a e expe ie ci g u i a y o p ostate- elated symptoms.

About U oze Capsules

U oze Capsules is a multi-i g edie t dieta y suppleme t featu i g zi c, lo gjack, maca, L-A gi i e HCl, Asia gi se g, eleuthe o gi se g, pumpki seed, ettle, a d a b oad bota ical ble d. U oze is positio ed withi the me ‘s well ess a d p ostate-suppo t suppleme t catego y.

The fo mulatio b i gs togethe ut itio al a d bota ical i g edie ts with diffe e t histo ies of use a d levels of scie tific i vestigatio . U de sta di g U oze equi es atte tio to its complete i g edie t decla atio , se vi g qua tities, ma ufactu i g quality, a d available evide ce co ce i g the fi ished p oduct.

This elease p ovides a i g edie t-focused ove view of U oze a d the co side atio s eleva t to multi-i g edie t dieta y suppleme ts. I g edie t desc iptio s alo e do ot establish cli ical effective ess, a d p oduct-specific health claims should be suppo ted by app op iate evide ce.

Disclaime : This elease is fo i fo matio al pu poses o ly a d does ot co stitute medical advice. Dieta y suppleme ts a e ot i te ded to diag ose, t eat, cu e, o p eve t disease. Co sult a qualified healthca e p ofessio al befo e usi g a suppleme t, pa ticula ly if you take medicatio , have a existi g health co ditio , o have co ce s about u i a y o p ostate health.

CONTACT: Email Suppo t: u oze @bestcsuppo t.com

Pho e Suppo t: +1 (719) 631-8514

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.

ShareTweet1ShareSendShare2
Previous Post

BluSky AI Chief AI Officer to Speak at OCP Global Summit on Open AI Infrastructure Standards

Next Post

Leonardo DRS Expands Federal Access to Mission-Critical Technologies Through NASA SEWP VI

Related Posts

Draganfly Announces Third Quarter Results

Va couve , BC., Nov. 10, 2026 (GLOBE NEWSWIRE) -- D aga fly I c. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“D aga fly” o the “Compa y”), a awa d-wi i g, i dust y-leadi g d o e solutio s a d systems develope , is pleased to...

Read moreDetails

Agility Robotics Files Customary Registration Statements Following Completion of Business Combination

Fili gs a e Sta da d Followi g a T a sactio of This Type; Does Not G a t Immediate Eligibility to U de lyi g Sha eholde Due to Lockup Rest ictio s All Existi g Agility Sha eholde s a d the Chu chill Spo so...

Read moreDetails

Datacentrex Reports Third Quarter 2026 Results and $30 Million Investment in Eagle LNG

Eagle LNG’s established custome base a d space p opulsio capabilities c eate additio al g owth oppo tu ities headi g i to 2027Repo ts positive thi d-qua te Adjusted EBITDA of $1.3 millio , compa ed with a $1.3 millio Adjusted EBITDA loss i Q2$30 millio i vestme...

Read moreDetails

iBio Reports Q1 Fiscal Year 2027 Financial Results and Provides Corporate Update

P ese ted additio al p ecli ical data suppo ti g IBIO-610’s pote tial to d ive fat selective weight loss i combi atio with GLP-1 the apy Completed dosi g i the si gle asce di g dose po tio of the Phase 1 cli ical t ial...

Read moreDetails

Marchex Returns to Revenue Growth and Profitability in Third Quarter 2026

Ge e ates $1.3 Millio i GAAP Net I come a d $2.6 Millio i Adjusted EBITDA ( et of eo ga izatio costs) Highlights Ea ly Comme cial Mome tum Followi g A che ia Acquisitio ; Appoi ts T avis Fai child P eside t SEATTLE, Nov. 10,...

Read moreDetails

Satellogic Reports Third Quarter 2026 Financial Results

Reco d Thi d Qua te Reve ue of $16.0 Millio , Up 342% Yea -ove -Yea , with a Seco d Co secutive Qua te of Positive Adjusted EBITDA Me li .01 Lau ched Octobe 1 a d Now Ope ati g, Adva ci g Pe siste t Global...

Read moreDetails

Rigetti Computing Reports Third Quarter 2026 Financial Results

Achieves 99.5% Media Two-Qubit Fidelity o 108-Qubit System, Fu the Validati g Chiplet-Based QPU A chitectu eBERKELEY, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Rigetti Computi g, I c. (Nasdaq: RGTI) (“Rigetti” o the “Compa y”), a pio ee i full-stack qua tum-classical computi g, today a ou ced fi...

Read moreDetails

GigaCloud Technology Inc to Participate in Three Upcoming Investor Conferences

EL MONTE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- GigaCloud Tech ology I c (Nasdaq: GCT) (“GigaCloud” o the “Compa y”), a pio ee of global e d-to-e d B2B tech ology solutio s fo la ge pa cel me cha dise, today a ou ced that E ica Wei,...

Read moreDetails

Mobile Infrastructure Reports Third Quarter 2026 Financial Results

RevPAS I c eases 16% D ive by Utilizatio Imp oveme t Co t act Volumes Up 13% a d T a sie t Volumes Up 11% Co fe e ce Call to be held at 4:30 PM Easte Time Today CINCINNATI, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Mobile I...

Read moreDetails

Astera Labs Announces Upcoming Financial Conference Participation

SAN JOSE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Aste a Labs, I c. (Nasdaq: ALAB), a leade i semico ducto -based co ectivity solutio s fo ack-scale AI i f ast uctu e, today a ou ced its pa ticipatio i the followi g fi a cial co fe...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Understanding Soulbound Tokens SBT Their Definition and Significance

    85 shares
    Share 34 Tweet 21
  • Top Cross-Chain DeFi Solutions to Watch by 2025

    190 shares
    Share 76 Tweet 48
  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    188 shares
    Share 75 Tweet 47
  • Discover the Best Metaverse Crypto Projects and Virtual Worlds 2025

    66 shares
    Share 26 Tweet 17
  • Discover 2025’s Top 5 Promising Low-Cap Crypto Gems

    111 shares
    Share 44 Tweet 28
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • Amdocs Announces First Quarter Fiscal 2027 Investor Conference Schedule
  • Intelligent Protection Management Corp. Reports Third Quarter 2026 Financial Results
  • LightPath Technologies Reports Fiscal 2027 First Quarter Financial Results
  • Draganfly Announces Third Quarter Results
  • Agility Robotics Files Customary Registration Statements Following Completion of Business Combination

RSS feed: Latest on Block3Wire Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS feed: Latest on Meta3Wire Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.